- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06134180
CONFIDENCE-AI Financial Education for Caregivers (CONFIDENCE-AI) (CONFIDENCE-AI)
March 23, 2024 updated by: Kylie Meyer, Case Western Reserve University
An AI-Embedded Intervention to Promote Financial Wellbeing Among Latino Family Caregivers
The intervention being tested, CONFIDENCE-AI is a refined version of the original CONFIDENCE intervention made to reduce psychological financial strain and improve management of out-of-pocket care costs while increasing caregiver resourcefulness skills.
Participants will be asked to participate in a 4-week intervention that includes participation in four, synchronous group-based Zoom sessions as well as between-session activities to apply learning.
Participants will also receive tailored text message notifications from the NeuViCare AI-powered app via text and will be able to submit questions to the app to receive financial well-being information related to caregiving.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kylie Meyer, PhD
- Phone Number: 2163681928
- Email: knm77@case.edu
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Recruiting
- Case Western Reserve University
-
Contact:
- Kylie Meyer, PhD
- Email: knm77@case.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Self-identified caregiver to a person diagnosed by a physician with Alzheimer's disease or related dementia at least 6 months ago
- Latino/Hispanic ethnicity.
Exclusion Criteria:
- Individuals who plan to place their family member in a nursing home in the next 3 months
- Unreliable access to internet, tablet or smart phone, and email
- Does not agree to participate in at least 3 of the 4 group sessions and/or register for the NeuViCare app
- Unable to read and speak in English or Spanish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CONFIDENCE AI
Participants will attend the 4-week CONFIDENCE-AI Program.
This program will include attending 4 group-based sessions delivered by videoconference.
Each session will last approximately 1.5 hours each and will cover topics such as how to budget, accessing community resources to displace the out-of-pocket costs of caregiving, asking for help, and more.
Participation will be supplemented by access to a digital app to support engagement, such as through text messaging and resources navigation support.
|
Multicomponent psychoeducational intervention focused on financial wellbeing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Financial Strain
Time Frame: The outcome measure will use the average change score from baseline scores until post-intervention (1 month post-baseline) and 2 months post-intervention (3-months after the baseline).
|
Financial strain will be measured using the 11-item Comprehensive Score for Financial Toxicity (COST) Scale.
A modified version of COST demonstrates validity and reliability when tested among cancer caregivers (α=0.91;
range: 0 to 44).
COST items are generic enough to be applicable to caregivers to persons PLWD without further modification (e.g., "I feel financially stressed").
Caregivers are asked to indicate if each statement applies to them "Not at all" (0) to "Very much" (4).
|
The outcome measure will use the average change score from baseline scores until post-intervention (1 month post-baseline) and 2 months post-intervention (3-months after the baseline).
|
Resourcefulness
Time Frame: The outcome measure will use the average change score from baseline scores until post-intervention (1 month post-baseline) and 2 months post-intervention (3-months after the baseline).
|
Resourcefulness is measured using the 28-item Caregiver Resourcefulness Scale (alpha=0.85;
Zauszniewski, 2006).
This scale has two factors: one focused on help-seeking and another on self-help.
Caregivers are asked the frequency at which they use different strategies to manage challenges, and may respond: Not at all like me (0), Pretty much not like me (1), A little bit not like me (2), A little bit like me (3), Pretty much like much like me (4), or Very much like me (5).
Items are added together to create a total score.
Scores range from 0 to 140, where higher scores indicate higher levels of resourcefulness.
The outcome measure will use the average change score from baseline scores
|
The outcome measure will use the average change score from baseline scores until post-intervention (1 month post-baseline) and 2 months post-intervention (3-months after the baseline).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Efficacy
Time Frame: The outcome measure will use the average change score from baseline scores until post-intervention (1 month post-baseline) and 2 months post-intervention (3-months after the baseline).
|
Self-efficacy is measured using the Caregiver Self-Efficacy Scale (Ritter et al., In Press).
This 8-item scale asks about multiples domains of self-efficacy (e.g., managing behavioral symptoms, accessing respite, and controlling upsetting thoughts).
It demonstrates high reliability (alpha=0.89)
and good test-retest reliability (0.73).
Participants rate the extent to which they are "Not confident at all" (1) to "Totally confident" (10).
Scores range from 8 (lowest level of self-efficacy) to 80 (highest level of self-efficacy).
|
The outcome measure will use the average change score from baseline scores until post-intervention (1 month post-baseline) and 2 months post-intervention (3-months after the baseline).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kylie Meyer, PhD, Case Western Reserve University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ritter PL, Sheth K, Stewart AL, Gallagher-Thompson D, Lorig K. Development and Evaluation of the Eight-Item Caregiver Self-Efficacy Scale (CSES-8). Gerontologist. 2022 Mar 28;62(3):e140-e149. doi: 10.1093/geront/gnaa174.
- Zauszniewski JA, Lai CY, Tithiphontumrong S. Development and testing of the Resourcefulness Scale for Older Adults. J Nurs Meas. 2006 Spring-Summer;14(1):57-68. doi: 10.1891/jnum.14.1.57.
- Sadigh G, Switchenko J, Weaver KE, Elchoufi D, Meisel J, Bilen MA, Lawson D, Cella D, El-Rayes B, Carlos R. Correlates of financial toxicity in adult cancer patients and their informal caregivers. Support Care Cancer. 2022 Jan;30(1):217-225. doi: 10.1007/s00520-021-06424-1. Epub 2021 Jul 13.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 23, 2024
Primary Completion (Estimated)
April 1, 2025
Study Completion (Estimated)
June 30, 2025
Study Registration Dates
First Submitted
November 6, 2023
First Submitted That Met QC Criteria
November 10, 2023
First Posted (Actual)
November 18, 2023
Study Record Updates
Last Update Posted (Actual)
March 26, 2024
Last Update Submitted That Met QC Criteria
March 23, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY20230876
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
De-identified survey data, such as pre- and post-test data, will be stored and available upon reasonable request with qualified investigators following the appropriate establishment of a data use agreement.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on CONFIDENCE-AI
-
University of HullUniversity of Southampton; Portsmouth Hospitals NHS Trust; University Hospitals...Recruiting
-
Amparo GmbHGDI Hub; AT 2030CompletedTranstibial AmputeesKenya
-
University of Massachusetts, WorcesterMerck Sharp & Dohme LLC; Baystate HealthRecruitingCOVID-19 VaccinationUnited States
-
BSN Medical GmbHCompleted
-
Bursa City HospitalCompletedLow Back Pain, Mechanical | Symptoms and SignsTurkey
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingPedagogical and Psycho-social Impact of in Situ SimulationFrance
-
University of NottinghamNational Institute for Health Research, United KingdomCompleted
-
Shandong UniversityCompletedArtificial Intelligence | Optical Enhancement Endoscopy | Magnifying EndoscopyChina
-
Methodist Health SystemEnrolling by invitationMock Code Training SimulationUnited States
-
The University of Hong KongRecruitingColonic Polyp | Colonic Cancer | Colonic AdenomaHong Kong